Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

Our outlook on global equities (both the MSCI ACWI and ACWI ex-US) remains positive and we continue to expect higher equity prices going forward.  In additional to highlighting important technical levels across major markets, we reiterate our recommendation to add exposure to global financials, and highlight a number of attractive Financial stocks, with an emphasis on UK and European names.

Our outlook on global equities (both the MSCI ACWI and ACWI ex-US) remains positive and we continue to expect higher equity prices going forward.  In additional to highlighting important technical levels across major markets, we reiterate our recommendation to add exposure to global financials, and highlight a number of attractive Financial stocks, with an emphasis on UK and European names. 

Global Equity Strategy: EU and UK Financial Stocks Are Attractive

Head of Research, IPOs & Placements, Aequitas Research

Sumeet Singh

Head of Research, IPOs & Placements

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Capital Markets

New China Life Insurance / Equity Capital Markets

<a href="https://www.smartkarma.com/entities/22588" target="_blank" data-smartkarma-citation="entities:22588:1">Swiss Re AG (SREN VX)</a> plans to raise US$460m by selling 7.3% of <a href="https://www.smartkarma.com/entities/377" target="_blank" data-smartkarma-citation="entities:377:1">New China Life Insurance Co Ltd (1336 HK)</a> . Swiss Re bought its stake from Zurich Insurance in 2013 and is now selling half its stake at nearly double the price it bought it at. The transformation for the company seems to be progressing well, however, this is now baked in to the price. The deal doesn't score well on our framework as valuations don't exactly appear cheap.<h2>Placement specifics</h2><ul><li>Company Name: New China Life Insurance Co…</li></ul>

Swiss Re AG (SREN VX) plans to raise US$460m by selling 7.3% of New China Life Insurance Co Ltd (1336 HK) . Swiss Re bought its stake from Zurich Insurance in 2013 and is now selling half its stake at nearly double the price it bought it at. The transformation for the company seems to be progressing well, however, this is now baked in to the price. The deal doesn't score well on our framework as valuations don't exactly appear cheap.Placement specificsCompany Name: New China Life Insurance Co…

New China Life Placement - Picked the Bottom for Buying, Hopefully Not the Top for Selling

MSCI Emerging Markets Index / Technical Analysis

Bullish technicals continue to support our call to overweight EM. We highlight actionable themes, as well as pullback opportunities in Europe, European luxury/apparel, UK homebuilders, EM chemicals, Japanese chemicals, and Japanese tech stocks.

Bullish technicals continue to support our call to overweight EM. We highlight actionable themes, as well as pullback opportunities in Europe, European luxury/apparel, UK homebuilders, EM chemicals, Japanese chemicals, and Japanese tech stocks.

Int'l Compass: Overweight EM; Actionable Themes in Europe and Japan

Independent Insight Provider

Stewart Paterson

Taurus Advisors LLP

Macroeconomics

Eurozone inflation announced today came in "on target" at 2% for the first time in 4 years!! To give credit where credit is due, between 2001 and October 2007 the ECB had a pretty impeccable record when it came to inflation targeting. CPI as measured by Eurostat oscillated between a low of 1.6% and a high of 2.5% and averaged 2.1%. However, 2007 seems a long time ago now and in the past decade or so CPI has been at 2% on just four occasions prior to today: on each of these CPI passed through 2%…

Eurozone inflation announced today came in "on target" at 2% for the first time in 4 years!! To give credit where credit is due, between 2001 and October 2007 the ECB had a pretty impeccable record when it came to inflation targeting. CPI as measured by Eurostat oscillated between a low of 1.6% and a high of 2.5% and averaged 2.1%. However, 2007 seems a long time ago now and in the past decade or so CPI has been at 2% on just four occasions prior to today: on each of these CPI passed through 2%…

The Personal consumption expenditure numbers in the US were released today. Income grew 0.4% MoM, an annualised rate of nearly 5% but the deflator matched the pace of growth so real incomes were stagnant. The PCE deflator is the Fed's preferred measure of inflation. The cynic would say this is because it perennially seems to undershoot CPI. However, even on this low-ball measure of inflation, the year on year rate of 1.9% is almost smack on the Fed's inflation target of 2% and the last 3 months…

The Personal consumption expenditure numbers in the US were released today. Income grew 0.4% MoM, an annualised rate of nearly 5% but the deflator matched the pace of growth so real incomes were stagnant. The PCE deflator is the Fed's preferred measure of inflation. The cynic would say this is because it perennially seems to undershoot CPI. However, even on this low-ball measure of inflation, the year on year rate of 1.9% is almost smack on the Fed's inflation target of 2% and the last 3 months…

Switzerland

Swiss Re AG offers reinsurance, insurance and insurance linked financial market products. The Company offers automobile, liability, accident, engineering, marine, aviation, life, and health insurance. Swiss Re also manages fixed-income and equity investments for itself and other insurance companies.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Swiss Re AG (SREN VX)

Global Equity Strategy: EU and UK Financial Stocks Are Attractive

Our outlook on global equities (both the MSCI ACWI and ACWI ex-US) remains positive and we continue to expect higher equity prices going forward. ...

Vermilion Research

New China Life Placement - Picked the Bottom for Buying, Hopefully Not the Top for Selling

Swiss Re AG (SREN VX) plans to raise US$460m by selling 7.3% of New China Life Insurance Co Ltd (1336 HK) . Swiss Re bought its stake from Zurich...

Sumeet Singh

Int'l Compass: Overweight EM; Actionable Themes in Europe and Japan

Bullish technicals continue to support our call to overweight EM. We highlight actionable themes, as well as pullback opportunities in Europe,...

Vermilion Research

Money Matters: Deutschland Über Alles?

Eurozone inflation announced today came in "on target" at 2% for the first time in 4 years!! To give credit where credit is due, between 2001 and...

Stewart Paterson

Money Matters: Ready for Lift-Off?

The Personal consumption expenditure numbers in the US were released today. Income grew 0.4% MoM, an annualised rate of nearly 5% but the deflator...

Stewart Paterson

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)